Search research articles
Contact Us
Filters
Showing results (181-190 of 199) with videos related to
Page
of 20
Sort By:
Targeted Oncology
|
September 28, 2018
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane
Annelieke E C A B Willemsen, Lioe-Fee de Geus-Oei, Maaike de Boer, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
March 21, 2013
Evaluation of an alternative in vitro test battery for detecting reproductive toxicants
A H Piersma, S Bosgra, M B M van Duursen, et al.
Cardiovascular and Interventional Radiology
|
January 9, 2023
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial
T M L Tong, M C Burgmans, F M Speetjens, et al.
The Oncologist
|
September 19, 2025
SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic colorectal carcinoma
Jorien B E Janssen, Kirti K Iyer, Sophie L Gerritse, et al.
Oncoimmunology
|
June 13, 2024
Exploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancer
Lotte Bakkerus, Beatriz Subtil, Hetty J Bontkes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2025
Effective TIL therapy for patients with checkpoint-resistant melanoma without lymphodepleting regimens requires interferon-alpha
Els M E Verdegaal, Anique L C Verpoorte, Monique K van der Kooij, et al.
Database : the Journal of Biological Databases and Curation
|
August 8, 2024
The overview of the BioRED (Biomedical Relation Extraction Dataset) track at BioCreative VIII
Rezarta Islamaj, Po-Ting Lai, Chih-Hsuan Wei, et al.
Clinical Genetics
|
May 16, 2017
The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers
J A Rijken, N D Niemeijer, M A Jonker, et al.
BMC Cancer
|
September 15, 2020
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial
Bastiaan M Privé, Marcel J R Janssen, Inge M van Oort, et al.
The Lancet. Oncology
|
April 2, 2026
[<sup>177</sup>Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
Bastiaan M Privé, Walter Noordzij, Constantijn H J Muselaers, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 199) with videos related to
Sort By:
Page
of 20
Targeted Oncology
|
September 28, 2018
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane
Annelieke E C A B Willemsen, Lioe-Fee de Geus-Oei, Maaike de Boer, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
March 21, 2013
Evaluation of an alternative in vitro test battery for detecting reproductive toxicants
A H Piersma, S Bosgra, M B M van Duursen, et al.
Cardiovascular and Interventional Radiology
|
January 9, 2023
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial
T M L Tong, M C Burgmans, F M Speetjens, et al.
The Oncologist
|
September 19, 2025
SUNRISE-CRC: a randomized phase II study of high-dose intermittent sunitinib versus trifluridine/tipiracil in metastatic colorectal carcinoma
Jorien B E Janssen, Kirti K Iyer, Sophie L Gerritse, et al.
Oncoimmunology
|
June 13, 2024
Exploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancer
Lotte Bakkerus, Beatriz Subtil, Hetty J Bontkes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2025
Effective TIL therapy for patients with checkpoint-resistant melanoma without lymphodepleting regimens requires interferon-alpha
Els M E Verdegaal, Anique L C Verpoorte, Monique K van der Kooij, et al.
Database : the Journal of Biological Databases and Curation
|
August 8, 2024
The overview of the BioRED (Biomedical Relation Extraction Dataset) track at BioCreative VIII
Rezarta Islamaj, Po-Ting Lai, Chih-Hsuan Wei, et al.
Clinical Genetics
|
May 16, 2017
The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers
J A Rijken, N D Niemeijer, M A Jonker, et al.
BMC Cancer
|
September 15, 2020
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial
Bastiaan M Privé, Marcel J R Janssen, Inge M van Oort, et al.
The Lancet. Oncology
|
April 2, 2026
[<sup>177</sup>Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
Bastiaan M Privé, Walter Noordzij, Constantijn H J Muselaers, et al.
Page
of 20